🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for CNS Metastases

Optimal Target Low-density Lipoprotein Cholesterol Level for Small Vessel Occlusion Stroke NCT06649240NA46 sites📍 Ansan📍 Anyang📍 Busan Seoul National University Hospital · Tests: Statins and/or Ezetimibe, PCSK9 inhibitor En Bloc Resection Versus Separation Surgery Combined With Radiotherapy for the Treatment of Spinal Oligometastatic Tumor. NCT06120426n/a1 site📍 Shanghai Shanghai Changzheng Hospital · Tests: total en bloc spondylectomy NK Cell Therapy for Malignant Solid Brain Tumors NCT07552233NA4 sites📍 Beijing📍 Qinhuangdao📍 Zhengzhou Peking University Third Hospital · Tests: Autologous NK cells A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the Brain NCT05419076Phase 27 sites📍 Basking Ridge📍 Middletown📍 Montvale Memorial Sloan Kettering Cancer Center · Tests: Stereotactic Radiosurgery, Cerebrospinal fluid collection A Study to Develop a Blood-based Test for Aiding the Diagnosis/Prognosis of Traumatic Brain Injury in Adults and for Monitoring the Development of Secondary Events in Patients Diagnosed With Traumatic Brain Injury NCT07455136n/a14 sites📍 Sacramento📍 San Francisco📍 Carmel Hoffmann-La Roche · Tests: Blood sample collection Frameless Stereotactic Radiosurgery for Intact Brain Metastases NCT02747303Phase 21 site📍 Chicago University of Chicago · Tests: Stereotactic Radiosurgery SRS & Abemaciclib w/wo Imlunestrant in the Management of HR+/HER2- Breast CA Brain Metastases NCT04923542Phase 1, Phase 22 sites📍 Tampa📍 Columbus H. Lee Moffitt Cancer Center and Research Institute · Tests: Stereotactic Radiosurgery (SRS), Abemaciclib, Endocrine therapy Longitudinal Autonomic Characterization as a Predictor for Secondary Medical Complications Post-SCI NCT07210437NA1 site📍 Rochester Mayo Clinic · Tests: Tests of sympathetic inhibition, Tests of above level sympathetic activation, Testing of below level sympathetic activa… Reducing the Incidence of Symptomatic Brain Metastases With MRI Surveillance NCT05692635Phase 21 site📍 Winston-Salem Wake Forest University Health Sciences · Tests: MRI of the Brain, Blood draws, Quality of Life Questionnaires, Gadolinium TY-9591 in the Patients With EGFR Mutations in Advanced NSCLC With Brain Metastases NCT05948813Phase 21 site📍 Beijing TYK Medicines, Inc · Tests: TY-9591, Osimertinib ARC-IM System to Manage Symptomatic Blood Pressure Instability Secondary to Chronic Spinal Cord Injury NCT07147296NA13 sites📍 Little Rock📍 Englewood📍 Miami ONWARD Medical, Inc. · Tests: ARC-IM System Implantation, ARC-IM Therapy (Group 1), ARC-IM Therapy (Group 2) Zanubrutinib With Pemetrexed to Treat Relapsed/Refractory Primary and Secondary Central Nervous System (CNS) Lymphomas NCT05681195Phase 21 site📍 Miami Baptist Health South Florida · Tests: Pemetrexed, Zanubrutinib, Autologous Stem Cell Transplant (ASCT), Whole Brain Radiation Therapy (WBRT) The Freiburg Registry on SpontanEous IntercrAnial Hypotension (SIH) & Post-duraL Puncture Headache (PDPH) NCT06711731n/a1 site📍 Freiburg im Breisgau University Hospital Freiburg Pharmacogenomic Contributions to Trihexyphenidyl Biotransformation and Response in Children With Dystonic Cerebral Palsy NCT06554288Phase 11 site📍 Kansas City Children's Mercy Hospital Kansas City · Tests: Trihexyphenidyl i-NEED: NEw migrainE Drugs Database NCT07103694n/a2 sites📍 Milan📍 Rome IRCCS San Raffaele Roma · Tests: anti-CGRP monoclonal antibodies, gepants, combination of sumatriptan and naproxen, ditan Ischemic Compression Technique Versus Jones Technique in Cervicogenic Headache Patients NCT06875869NA1 site📍 Bahawalpur Riphah International University · Tests: Jones technique, Ischemic compression therapy Developing a New MRI Technique to Understand Changes in Brain Tumors After Treatment NCT05559853n/a1 site📍 New York Memorial Sloan Kettering Cancer Center · Tests: CEST-MRF A Phase II Study of Nivolumab With Ipilimumab and Cabozantinib in Patients With Untreated Renal Cell Carcinoma Brain Metastases NCT05048212Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Nivolumab, Ipilimumab, Cabozantinib Phase I Study of Fractionated Stereotactic Radiation Therapy NCT03726359NA1 site📍 The Bronx Albert Einstein College of Medicine · Tests: Fractionated Stereotactic Radiation Therapy (FSRT) Gepant treAtments: EffectIveNess and tolERability (GAINER) NCT05903027n/a2 sites📍 Florence📍 Pavia University of Florence · Tests: Rimegepant 75 MG Disintegrating Oral Tablet SBRT Technique Implementation for Spinal Metastases Irradiation NCT07429422NA2 sites📍 Ljubljana📍 Ljubljana Institute of Oncology Ljubljana · Tests: Stereotactic Body Radiotherapy (SBRT) for Spinal Metastases Blood-brain Barrier (BBB) Opening Using Exablate Focused Ultrasound With Standard of Care Treatment of NSCLC Brain Mets NCT05317858Phase 316 sites📍 Phoenix📍 Newport Beach📍 Fort Lauderdale InSightec · Tests: Blood Brain Barrier Opening - Oncology, Pembrolizumab, Atezolizumab, Cemiplimab, Nivolumab A Study to Evaluate the Efficacy of Osimertinib With Early Intervention SRS Treatment Compared to the Continuation of Osimertinib Alone, in Patients With EGFR Mutated NSCLC and Asymptomatic Brain Metastases NCT05033691NA1 site📍 Jerusalem Hadassah Medical Organization · Tests: Stereotactic surgery The Southern-Norway Post-Stroke Atrial Fibrillation Study NCT07407790NA1 site📍 Kristiansand Sorlandet Hospital HF · Tests: Patch ECG, Standard Care (in control arm) Nitroglycerin Plus Radiotherapy Versus Conventional Radiotherapy in Patients With Lung Cancer. NCT06238882NA1 site📍 Mexico City Instituto Nacional de Cancerologia de Mexico · Tests: Nitroglycerin Stereotactic Radiation for Growing/Changing Brain Metastases With Same-Day Radiation Planning and Treatment With Margin Reduction NCT07132190Phase 21 site📍 Boston Ayal A. Aizer, MD · Tests: Linear accelerator-based stereotactic radiation for brain metastases using 0mm or 1mm PTV A Prospective Cohort Study of Zorifertinib as a First-line Treatment in Patients With Epidermal Growth Factor Receptor-mutant Advanced Non-small Cell Lung Cancer With Central Nervous System (CNS) Metastases NCT07143045n/a34 sites📍 Hefei📍 Beijing📍 Beijing Alpha Biopharma (Jiangsu) Co., Ltd. · Tests: zorifertinib Furmonertinib Combined With Intrathecal Chemotherapy and Stereotactic Radiotherapy (SRT) for EGFR-Mutated NSCLC Patients With Brain Parenchymal and Leptomeningeal Metastases NCT07304739Phase 23 sites📍 Cangzhou📍 Tianjin📍 Tianjin Tianjin Medical University Cancer Institute and Hospital · Tests: Furmonertinib, Intrathecal chemotherapy, Stereotactic radiotherapy Evaluating High-dose Furmonertinib with Bevacizumab and Pemetrexed for EGFRm NSCLC with Leptomeningeal Metastasis NCT06643000NA2 sites📍 Zhengzhou📍 Zhengzhou Henan Cancer Hospital · Tests: furmonertinib Stereotactic Radiosurgery Dose Escalation for Brain Metastases NCT02390518Phase 11 site📍 Salt Lake City University of Utah · Tests: Stereotactic Radiosurgery
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy